# BICO Group

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/en/companies/bicogroup).

## Overview

BICO Group AB is a company focused on enabling and automating life science laboratories through advanced technologies. The company offers a range of products and services including lab automation projects, instruments, bioinks, tissues, and consumables. BICO also provides services such as service contracts, contract manufacturing, and software solutions. The company's strategy is centered around sustainable profitable growth and automating the life science lab of the future.

## Products & services

• Lab automation projects
• Instruments
• Bioinks
• Tissues
• Consumables
• Service contracts
• Contract manufacturing

- **Lab Automation** (26%) — Includes automation projects and instruments for labs
- **Life Science Solutions** (74%) — Comprises bioinks, tissues, and consumables

- Lab automation projects
- Instruments
- Bioinks
- Tissues
- Consumables
- Service contracts
- Contract manufacturing

## Customers

BICO Group serves a diverse range of customers primarily in the life sciences sector. Their customer base includes research institutions, pharmaceutical companies, and biotechnology firms seeking advanced lab automation and bioengineering solutions. These customers are drawn to BICO's innovative products that enhance lab efficiency and enable cutting-edge research. The company's service contracts and custom manufacturing solutions are particularly appealing to organizations looking to optimize their laboratory operations.

- **Research Institutions** (primary) — Purchase lab automation and bioinks for research purposes
- **Pharmaceutical Companies** (primary) — Buy tissues and consumables for drug development
- **Biotechnology Firms** (secondary) — Require consumables and contract manufacturing

- Research institutions seeking lab automation
- Pharmaceutical companies needing bioinks and tissues
- Biotechnology firms interested in consumables
- Organizations requiring service contracts for lab equipment
- Customers looking for contract manufacturing solutions

## Geography

BICO Group operates globally with a strong presence in the life sciences markets. The company has manufacturing and operational facilities strategically located to serve key markets in Europe and North America. This geographic distribution allows BICO to efficiently meet the demands of its diverse customer base. The company's strategic focus on these regions is driven by the high concentration of research institutions and biotech firms.

- Strong presence in Europe and North America
- Manufacturing facilities strategically located for key markets
- Focus on regions with high concentration of research institutions
- Geographic distribution supports diverse customer base

## Strategy

BICO's strategic priorities include driving sustainable profitable growth and enhancing its product offerings in lab automation and life science solutions. The company aims to achieve double-digit organic growth and improve its EBITDA margin. Strategic divestments, such as the sale of MatTek and Visikol, align with BICO's focus on core competencies. The updated BICO 2.0 strategy emphasizes innovation and operational efficiency to maintain competitive advantage.

- **Sustainable Profitable Growth** (medium-term) — To maintain competitive advantage and shareholder value
- **Innovation in Lab Automation** (long-term) — To lead in life science lab automation solutions

- Focus on sustainable profitable growth
- Enhance product offerings in lab automation
- Achieve double-digit organic growth
- Improve EBITDA margin
- Strategic divestments to focus on core competencies

## Risks

BICO faces several risks including macroeconomic uncertainties, changes in regulatory environments, and operational challenges in lab automation. The company is also exposed to financial risks such as currency fluctuations and interest rate changes. Additionally, the ability to attract and retain skilled employees is crucial for maintaining innovation and operational excellence. The divestment of non-core businesses like MatTek and Visikol helps mitigate some operational risks by allowing BICO to focus on its core strengths.

- **Macroeconomic Uncertainties** [high] — Affect demand for lab automation solutions
- **Regulatory Changes** [medium] — Impact product compliance and market access
- **Currency Fluctuations** [medium] — Affect financial performance due to global operations

- Macroeconomic uncertainties affecting demand
- Regulatory changes impacting product compliance
- Operational challenges in lab automation
- Currency fluctuations affecting financial performance
- Interest rate changes impacting financing costs
- Need to attract and retain skilled employees

## Accounting

BICO's financial statements are influenced by several critical accounting matters, including revenue recognition and impairment of goodwill. The company applies IFRS standards, with revenue recognized based on the transfer of promised products and services. Seasonal variations also affect BICO's financial performance, with sales typically increasing towards the end of the year. The company has adjusted its impairment testing methodology for goodwill, impacting reported figures retrospectively.

- **Revenue Recognition** — Significant on revenue reporting
- **Goodwill Impairment** — Material on financial statements

- Revenue recognition based on transfer of products/services
- Seasonal variations affect financial performance
- Impairment testing methodology for goodwill adjusted
- Estimates and assessments impact reported amounts

---

*Last updated: 2026-08-11T04:04:51.197318+00:00*